E-MAIL: [email protected]
FDA Proposes to Exclude Semaglutide, Tirzepatide, and Liraglutide on 503B Bulks List
062026.05
Reusable Pen Device with Cartridge Replacement for Biopharma Companies
272026.04
How do COP RTU vials reduce the adsorption of host cell protein (HCP) to DNA?
Reusable Injection Pen for Biologics: ISO13485-Certified Manufacturing
Copyright © Shijiazhuang Xinfuda Medical Packaging Co., Ltd. All Rights
Reserved Powered by
MAKE AN ENQUIRY